Sobi

News:   Sobi is an international biopharmaceutical company focused on rare diseases. We are dedicated to providing access to innovative treatments that transform life for people with rare diseases.

Sobi at a glance

At Sobi, we are transforming life for people with rare diseases. As an international biopharmaceutical company, we provide access to innovative treatments in the areas of haematology, immunology and specialty care.

  • Two therapeutic areas – Haematology and Immunology – and a portfolio of products within Specialty Care
  • Our extended half-life factor replacement treatments are the most prescribed treatments for haemophilia A and B respectively in several markets
  • A strong portfolio of on-market products, and an extensive portfolio of pre-market assets
  • An international biopharmaceutical company covering the entire value chain
  • We put our focus where we can have the greatest impact, in late-stage research and development, and in patient access and commercialisation
  • Revenue of SEK 15.3 bn for the full year 2020
  • Global Head Office in Stockholm, with offices in more than 30 countries, delivering treatments to patients in more than 70 countries
  • Approximately 1,500 employees globally

Rare diseases

There are thought to be around 6,000 distinct rare diseases, affecting more than 300 million people around the world. Yet around 95 per cent of rare diseases currently have no approved treatment.

95% of rare diseases currently have no approved treatment

300 million people affected

75% of rare diseases affect children

The rare disease space is unlike any other in medicine. In Europe, a rare disease is defined as one affecting fewer than one person per 2,000. In the US, the Orphan Drug Act of 1983 defines a rare disease as a condition affecting fewer than 200,000 people.

High unmet medical need

An estimated 75 per cent of identified rare diseases affect children, often having a devastating effect on life expectancy and quality of life. Around 30 per cent of children diagnosed with a rare disease will not live to see their fifth birthday. The severe nature of many rare diseases often leads to high levels of distress for patients and their families, with an accompanying high treatment burden.

Around 80 per cent of rare diseases are inherited rather than acquired: they involve a defect in the genes that tell our bodies how to work. As a result, the body may fail to produce an essential enzyme or protein, for example, or its own immune defences may attack its own systems.

Many physicians may never have seen a specific rare condition before; as a result, many cases can go undiagnosed for years.

Rare challenges

The rare disease landscape presents specific scientific, medical and commercial challenges. They range from understanding the biology of a disease, identifying molecules that can become successful treatments, developing the complex biopharmaceutical processes to manufacture a drug, designing and running clinical trials in extremely small patient populations, obtaining regulatory approvals, negotiating pricing and reimbursement, through to working with healthcare professionals and patients to ensure access for the people who need the treatment.

Such treatments are referred to as “orphan drugs,” intended to treat diseases so rare that companies would be reluctant to develop them under normal market conditions.

Therapeutic areas

Our therapies are concentrated within the areas of haematology, immunology and specialty care.

Within haematology we provide extended half-life recombinant replacement clotting factor treatments for haemophilia A and haemophilia B, and a treatment for thrombocytopenia, a condition characterised by abnormally low levels of platelets in the blood.

The field of immunology has long been at the heart of what we do at Sobi, allowing us to gain extensive experience over many years. Our Immunology portfolio allows the treatment of serious, disabling or even life-threatening diseases.

We also provide important specialty treatments in the area of genetics and metabolism.

Haematology

The area of haematology covers a wide range of conditions, including those involving red and white blood cells, coagulation and platelets, and bone marrow.

Haematology | Sobi

Immunology

The field of immunology has long been at the heart of what we do at Sobi, allowing us to gain extensive experience over many years.

Immunology | Sobi

Specialty Care

We provide products for the treatment of genetic and metabolic diseases as well as a number of specialist indications.

Specialty Care portfolio | Sobi

Research and development

We bring new treatments to market, expand our existing products into new indications and regions where they address unmet medical need, and gather real-world evidence for available products.

Our R&D is focused on late-stage research within the areas of Haematology and Immunology, where our pre-market assets represent considerable value.

News

How to celebrate Christmas at Expo

News:  With Christmas just around the corner many festive activities are taking place at Expo. In the Swedish pavilion a Christmas tree was decorated on Monday to get into the Christmas spirit.

Make your own print at the Co-creation stage

News:  At the Co-creation stage at the Swedish pavilion you can choose your own print through 3D-glasses, to put on a t-shirt or tote bag. Anders Strindlund, store supervisor at the Swedish impact store, shows how the prints are made.

UAE Minister on deploying AI to improve quality of life

News:  AI Minister Omar Al Olama discusses investing in infrastructure to be part of the "trillions of dollars of impact" that he anticipates 5G will have, and utilizing AI for efficiency gains and to improve quality of life.

November 27 - chess world championship started

News:  ExpoUpdate publishes a show summarizing the latest news and stories from Expo and the Swedish pavilion in Dubai. This week focus has been on the start of chess world championship.

How to get around Expo - three different ways

News:  The Expo site is huge, so in order to visit all of the 192 pavilions you have to be smart. ExpoUpdate tried out the different ways to get around Expo.

Towards a greener future - these are the strategies

News:  A sustainable future was the topic when the Swedish Business Council invited to a Nordic sundowner at the pavilion this week. The two Swedish companies Alfa Laval and Tetra Pak was there to talk about their plans for a greener future. 

Chess master ready to defend his title

News:  The chess world championship will be held at Expo in Dubai, between Norwegian world champion Magnus Carlsen and Russian challenger Ian Nepomniachtchi. On Wednesday there was an opening ceremony and on Friday they will play their first game out of 14.

More than four million visitors in seven weeks

News:  In seven weeks 4,1 million people have visited Expo in Dubai, according to The National News. The interest for the online experience has been big as well with 22 million virtual visitors.

3 cool hotels in northern Sweden

VisitSweden:  Sweden is studded with unique hotels close to nature, offering a once in a lifetime experience. Here are three cool accommodations in northern Sweden, perfect for a winter wonderland vacation. Which one will be on top of your bucket list?